Jan 20,2022 12:05 PM
Granules India surged 2% to emerge as the top gainer in the sector.
|Resolution Type||Description Of Resolution||IiAS Recommendation|
|Name||LTP||PE||Mar Cap||NP Qtr||Div. Yld||Sales Qtr||BV|
|Sun Pharmaceuticals Industries Ltd||884.00||108.74||194,118.20||809.07||0.93||4,120.93||113.47|
|Divis Laboratories Ltd||3,850.00||52.64||110,935.34||606.39||0.48||1,967.86||372.89|
|Dr Reddys Laboratories Ltd||4,400.00||46.28||74,862.73||449.00||0.56||3,809.50||1,049.62|
|Piramal Enterprises Ltd||2,530.00||235.51||60,310.32||34.34||1.23||515.35||962.90|
Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.
Divis Laboratories Ltd is an India based manufacturer of Active Pharmaceutical Ingredients (APIs) and Intermediates. The company is engaged in manufacture of leading generic compounds, Nutraceutical ingredients and custom synthesis of APIs and intermediates for global innovator companies. Divis is among the largest pharmaceutical companies in India with a portfolio of 120 products across diverse therapeutic areas. The company has four ... More
Jan 24, 2022 03:47 AM
The company’s standalone revenue stood at Rs1,342.92cr, up 29.39% yoy and 4.51% qoq.
06 Nov 2021
28 Oct 2021
Quarterly ResultsFurther to our intimation dated October 28, 2021, we would like to inform that the ... More
30 Aug 2021
19 Jul 2021
AGM 30/08/2021We hereby inform that the 31st Annual General Meeting of the Company is scheduled to b... More
29 May 2021
17 Aug 2021
As per enclosed... More
Verify your OTP
Didn't receive the OTP yet? Resend